BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16116023)

  • 1. Pralidoxime rescues both muscarinic and nicotinic systems.
    Petroianu GA
    Anesth Analg; 2005 Sep; 101(3):926-927. PubMed ID: 16116023
    [No Abstract]   [Full Text] [Related]  

  • 2. The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors.
    Soukup O; Jun D; Tobin G; Kuca K
    Arch Toxicol; 2013 Apr; 87(4):711-9. PubMed ID: 23179755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and median effective doses of oxime therapies against percutaneous organophosphorus pesticide and nerve agent challenges in the Hartley guinea pig.
    Snider TH; Babin MC; Jett DA; Platoff GE; Yeung DT
    J Toxicol Sci; 2016; 41(4):511-21. PubMed ID: 27432237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substituted monoquaternary oximes as reactivators of cyclosarin--and chlorpyrifos--inhibited acetylcholinesterase.
    Racakova V; Hrabinova M; Jun D; Kuca K
    Arh Hig Rada Toksikol; 2006 Dec; 57(4):387-90. PubMed ID: 17265677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivation of VX-inhibited cholinesterase by 2-PAM and HS-6 in rats.
    Harris LW; Stitcher DL
    Drug Chem Toxicol; 1983; 6(3):235-40. PubMed ID: 6628257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 2-pyridine aldoxime methochloride on cerebral acetylcholinesterase activity and respiration in cats poisoned with sarin.
    Murtha EF; Harris LW
    Life Sci; 1980 Nov; 27(20):1869-73. PubMed ID: 7470233
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain neuronal RNA metabolism during acute soman toxication: effects of antidotal pretreatments.
    Doebler JA; Bocan TM; Moore RA; Shih TM; Anthony A
    Neurochem Res; 1983 Aug; 8(8):997-1011. PubMed ID: 6194444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of obidoxime, diacetylmonoxime, pralidoxime, and two less hydrophilic derivatives of pralidoxime upon the cholinesterase inhibition and the pressor effect by paraoxon in the rat.
    de Neef JH; Porsius AJ
    Toxicol Appl Pharmacol; 1982 Nov; 66(2):244-51. PubMed ID: 6761901
    [No Abstract]   [Full Text] [Related]  

  • 9. O-Substituted derivatives of pralidoxime: muscarinic properties and protection against soman effects in rats.
    Loke WK; Sim MK; Go ML
    Eur J Pharmacol; 2002 May; 442(3):279-87. PubMed ID: 12065082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An insect bioassay as a primary screen for nerve agent antidotes.
    Golenda CF; Wirtz RA; Andre RG; Roberts DR
    Mil Med; 1986 May; 151(5):258-63. PubMed ID: 3086771
    [No Abstract]   [Full Text] [Related]  

  • 11. In silico and in vitro evaluation of two novel oximes (K378 and K727) in comparison to K-27 and pralidoxime against paraoxon-ethyl intoxication.
    Arshad M; Fatmi MQ; Musilek K; Hussain A; Kuca K; Petroianu G; Kalasz H; Nurulain SM
    Toxicol Mech Methods; 2018 Jan; 28(1):62-68. PubMed ID: 28722512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency of novel oximes to reactivate sarin inhibited human cholinesterases.
    Jun D; Kuca K; Picha J; Koleckar V; Marek J
    Drug Chem Toxicol; 2008; 31(1):1-9. PubMed ID: 18161504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy of HI6 and 2-PAM against soman, tabun, sarin, and VX in the rabbit.
    Koplovitz I; Stewart JR
    Toxicol Lett; 1994 Feb; 70(3):269-79. PubMed ID: 8284794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the toxicity, pathology, and treatment of cyclohexylmethylphosphonofluoridate (CMPF) poisoning in rhesus monkeys.
    Koplovitz I; Gresham VC; Dochterman LW; Kaminskis A; Stewart JR
    Arch Toxicol; 1992; 66(9):622-8. PubMed ID: 1482284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring exposure of passerines to acephate, dicrotophos, and malathion using cholinesterase reactivation.
    Maul JD; Farris JL
    Bull Environ Contam Toxicol; 2004 Oct; 73(4):682-9. PubMed ID: 15389333
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparing therapeutic and prophylactic protection against the lethal effect of paraoxon.
    Petrikovics I; Papahadjopoulos D; Hong K; Cheng TC; Baskin SI; Jiang J; Jaszberenyi JC; Logue BA; Szilasi M; McGuinn WD; Way JL
    Toxicol Sci; 2004 Feb; 77(2):258-62. PubMed ID: 12857941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of atropine and pralidoxime on neuronal actions of paraoxon in rat hippocampal slices.
    Narimatsu E; Niiya T; Kawamata T; Kawamata M; Yamakage M
    Neurosci Res; 2010 Dec; 68(4):276-84. PubMed ID: 20816709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
    Bartosova L; Kuca K; Jun D; Kunesova G
    Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinesterase inhibition by aluminium phosphide poisoning in rats and effects of atropine and pralidoxime chloride.
    Mittra S; Peshin SS; Lall SB
    Acta Pharmacol Sin; 2001 Jan; 22(1):37-9. PubMed ID: 11730559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of K074 and pralidoxime on antioxidant and acetylcholinesterase response in malathion-poisoned mice.
    dos Santos AA; dos Santos DB; Ribeiro RP; Colle D; Peres KC; Hermes J; Barbosa AM; Dafré AL; de Bem AF; Kuca K; Farina M
    Neurotoxicology; 2011 Dec; 32(6):888-95. PubMed ID: 21723318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.